Manufacturing Defect Causes Ban on the Digoxin
Digoxin, also known as Digitek, digitalis, Lanoxicaps and Lanoxin is a refined plant, a purified cardiac glycoside. It is used for the treatment of different type of heart conditions like atrial flutter and atrial fibrillation, for abnormal heartbeats and heart failure that cannot be controlled by other medicines. Digoxin is manufactured under the brand name Digitek , Lanoxicaps and Lanoxin. Actavis Totowa LLC, also known as Amide Pharmaceutical, Inc manufactures it manufactures them in the United States. Its headquarters are located at the New Jercy.
The Mylan Pharmaceuticals manufactured Digitek pills with double amount of active ingredient, thus increasing the side effects. Common side effects associated with the use of Digitek are given below:
- Dizziness
- Diarrhea
- Nausea
- Loss of appetite
- Blurred vision
- Agitation
- Confusion
- Depression
- Vomiting
- Visual disturbances
- Drowsiness
- Nightmares
In addition to the above-mentioned side effects, there are other side effects like delirium, acute psychosis and amnesia. It may also cause heart complications like heart failure and arrythmia episodes.
Over the past one month, the press has reported several reports of complications, illnesses and death related with the overdose of Digitek. Due to the recall of Digoxin tablets along with some reports by FDA have increased that chances of Mass Tort Law Suit.